Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.
Diamantopoulos PT, Stafylidis C, Vlachopoulou D, Kontandreopoulou CN, Giannakopoulou N, Vardaka M, Mpouhla A, Mastrogianni E, Variami E, Galanopoulos A, Pappa V, Psichogiou M, Hatzakis A, Viniou NA.
Diamantopoulos PT, et al. Among authors: hatzakis a.
Ther Adv Hematol. 2022 May 23;13:20406207221090150. doi: 10.1177/20406207221090150. eCollection 2022.
Ther Adv Hematol. 2022.
PMID: 35646300
Free PMC article.